Predicting Response and Survival in Chemotherapy-Treated Triple-Negative Breast Cancer

ABSTRACT: Gene expression data of pre-treatment samples of GEICAM2006-03 TNBC trial Patients were randomized to carboplatin or no carboplatin in the neoadjuvant setting In the study presented here, a well-defined cohort of 69 breast samples were used to acquire expression profiles of a total of 543 unique genes (+5 HK genes)

ORGANISM(S): Homo sapiens

SUBMITTER: Aleix Prat 

PROVIDER: E-GEOD-58479 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress